Major primary bile salts repress Salmonella enterica serovar Typhimurium invasiveness partly via the efflux regulatory locus ramRA
- PMID: 38410385
- PMCID: PMC10895713
- DOI: 10.3389/fmicb.2024.1338261
Major primary bile salts repress Salmonella enterica serovar Typhimurium invasiveness partly via the efflux regulatory locus ramRA
Abstract
Bile represses Salmonella enterica serovar Typhimurium (S. Typhimurium) intestinal cell invasion, but it remains unclear which bile components and mechanisms are implicated. Previous studies reported that bile inhibits the RamR binding to the ramA promoter, resulting in ramA increased transcription, and that ramA overexpression is associated to decreased expression of type III secretion system 1 (TTSS-1) invasion genes and to impaired intestinal cell invasiveness in S. Typhimurium. In this study, we assessed the possible involvement of the ramRA multidrug efflux regulatory locus and individual bile salts in the bile-mediated repression of S. Typhimurium invasion, using Caco-2 intestinal epithelial cells and S. Typhimurium strain ATCC 14028s. Our results indicate that (i) major primary bile salts, chenodeoxycholate and its conjugated-derivative salts, cholate, and deoxycholate, activate ramA transcription in a RamR-dependent manner, and (ii) it results in repression of hilA, encoding the master activator of TTSS-1 genes, and as a consequence in the repression of cellular invasiveness. On the other hand, crude ox bile extract and cholate were also shown to repress the transcription of hilA independently of RamR, and to inhibit cell invasion independently of ramRA. Altogether, these data suggest that bile-mediated repression of S. Typhimurium invasion occurs through pleiotropic effects involving partly ramRA, as well as other unknown regulatory pathways. Bile components other than the bile salts used in this study might also participate in this phenomenon.
Keywords: RamR; Salmonella; Typhimurium; bile; intestinal; invasion; ramA; regulation.
Copyright © 2024 Giraud, Baucheron, Foubert, Doublet, Nishino and Cloeckaert.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.
Figures
crude bile extract,
chenodeoxycholic acid-derived salts (CDC, chenodeoxycholate; TCDC, taurochenodeoxycholate; GCDC, glycochenodeoxycholate) and
cholic acid-derived salts (C, cholate; DC, deoxycholate; TC, taurocholate; GC, glycocholate).
crude bile extract,
chenodeoxycholate (CDC),
cholate (C), and
deoxycholate (DC). Asterisks indicate significant differences (NS, non-significant; *P < 0.05, **P < 0.01, ***P < 0.001). ND, not determined.
, +) of crude bile extract at 25.6 g/L, of the WT S. Typhimurium strain 14028s and its ramRA::kan deletion mutant complemented with a pramA plasmid. Bars indicate the percentage of attached/internalized bacteria ± standard error of the mean. Asterisks indicate significant differences (***P < 0.001).
References
LinkOut - more resources
Full Text Sources
